Detalhe da pesquisa
1.
Development and validation of a predictive mortality risk score from a European hemodialysis cohort.
Kidney Int
; 87(5): 996-1008, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25651366
2.
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.
Pharmacoepidemiol Drug Saf
; 24(7): 738-47, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26011775
3.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(3): 242-51, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25851955
4.
Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study.
BMC Nephrol
; 13: 140, 2012 Oct 29.
Artigo
Inglês
| MEDLINE | ID: mdl-23106934
5.
Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.
Cancer Chemother Pharmacol
; 88(2): 189-202, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33903938
6.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(4): 368, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26096896
7.
Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism.
Nefrologia
; 36(2): 164-75, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26654696
8.
Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism / Efectividad y persistencia de los tratamientos del hiperparatiroidismo secundario en pacientes incidentes en hemodiálisis
Nefrología (Madr.)
; 36(2): 164-175, mar.-abr. 2016. tab, graf
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-150911